The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...

The deal extends an agreement to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Authorities said they found about 56 grams of Methamphetamine (ICE), about 112 grams of crack and powder Cocaine, about 500 ...

Alloy Therapeutics ("Alloy"), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...